JP-PC-MR at table

Alternative Allocation Strategy

  • Asset Class Alternatives

Overview

The GMO Alternative Allocation Strategy seeks to generate positive total return, rather than "relative" return, by investing in a diversified portfolio of underlying alternative strategies, all run by GMO teams. The Strategy seeks low beta and low correlation to traditional equities and other risk assets.

Underlying strategies will include but are not be limited to: merger arbitrage/event-driven, global macro, fixed income absolute return, asset allocation long/short, long/short and market neutral equities, high yield, and systematic put writing strategies. The Strategy’s success will be linked to the following differentiated features:

  • Dynamic allocation on two levels:
    • Top-down. The GMO Asset Allocation team will calibrate the aggregate level of portfolio risk, especially at valuation extremes, when investors need risk management the most.
    • Bottom-up. The underlying investment strategies will dynamically alter exposures and risk levels in an alpha-proportional manner.
  • Diversity of risk and return.
    • Portfolio construction and risk management will incorporate both low statistical and intrinsic correlations.
    • The team will diversify by return source, combining strategies that are more skill-based, i.e. true alpha strategies, with those that harvest alternative risk premia.
  • Efficient use of Capital. The team will employ overlays that enable exposures greater than 100%, when appropriate, but without borrowing or financing from a prime broker.
  • Transparency. All strategies are run in-house. The portfolio management team has transparency, not just of positions but of the rationale and conviction levels of the underlying teams.
  • Experience. GMO has over 20 years of experience in managing individual alternative strategies and packaging them together into multi-strategy solutions.

Facts

Performance

Management

Inker_Ben

Ben Inker

Head of Asset Allocation

Mr. Inker is head of GMO’s Asset Allocation team and a member of the GMO Board of Directors. He joined GMO in 1992 following the completion of his B.A. in Economics from Yale University.  In his years at GMO, Mr. Inker has served as an analyst for the Quantitative Equity and Asset Allocation teams, as a portfolio manager of several equity and asset allocation portfolios, as co-head of International Quantitative Equities, and as CIO of Quantitative Developed Equities.  He is a CFA charterholder.

Brannan_BJ

B.J. Brannan

Mr. Brannan is a member of GMO’s Asset Allocation team. Previously, he was a member of GMO’s investments control group. Prior to joining GMO in 2006, Mr. Brannan worked at Investors Bank & Trust as an account manager for fund accounting. Mr. Brannan earned his BA in Business Management from University of Massachusetts Amherst and MBA from Boston University. He is a CFA charterholder.

Kadnar_Matt

Matt Kadnar

Mr. Kadnar is a member of GMO’s Asset Allocation team. Prior to joining GMO in 2004, he was an investment specialist and consultant relations manager at Putnam Investments. Previously, he served as in-house counsel for LPL Financial Services and as a senior associate at Melick & Porter, LLP. Mr. Kadnar has a B.S. from Boston College majoring in Finance and Philosophy and a J.D. from St. Louis University School of Law. He is a CFA charterholder.

Risks

Risks associated with investing in the Strategy may include: Management and Operational Risk, Leveraging Risk, Derivatives and Short Sales Risk, Market Risk - Equities, and Market Risk - Fixed Income.